{"id":13000,"name":"Dimension (formerly The 2nd Dimension)","slug":"dimension-formerly-the-2nd-dimension","website":"https://www.dimensions.com/","hqGeo":null,"stageFocus":["Seed","Series A","Series B","Growth"],"sectorTags":["Other","AI / ML","Developer Tools"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"Life sciences and technology fund backing companies across stages in biotech platforms, software infrastructure, lab tools, clinical development, manufacturing and commercialization, plus AI/ML.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Atomic AI","companyUrl":null,"stage":"Series A","sector":"Biotech / AI Drug Discovery","investmentYear":null,"description":"A biotechnology company combining machine learning and structural biology to predict RNA structures and design RNA-targeted small molecules and RNA therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":"Dimension I"},{"companyName":"Inceptive","companyUrl":null,"stage":"Series A / Venture Round","sector":"Biotech / Generative AI","investmentYear":null,"description":"A biotechnology company developing \"biological software\" by using deep learning models to design novel, highly targeted RNA molecules.","amountUsd":null,"relevanceNote":null,"fundName":"Dimension I"},{"companyName":"Superluminal Medicines","companyUrl":null,"stage":"Seed","sector":"Biotech / AI Drug Discovery","investmentYear":null,"description":"A drug discovery company utilizing generative AI, machine learning, and structural biology to design small molecule therapeutics targeting G protein-coupled receptors (GPCRs).","amountUsd":null,"relevanceNote":null,"fundName":"Dimension I"},{"companyName":"Enveda Biosciences","companyUrl":null,"stage":"Series B1","sector":"Biotech / AI Drug Discovery","investmentYear":null,"description":"A biotechnology company using AI, metabolomics, and mass spectrometry to identify and translate chemistry from natural products into new medicines.","amountUsd":null,"relevanceNote":null,"fundName":"Dimension I"},{"companyName":"Basecamp Research","companyUrl":null,"stage":"Series B","sector":"Biotech / AI & Biodesign","investmentYear":null,"description":"A biotechnology company mapping global biodiversity to build a foundational dataset for designing novel proteins and enzymes using artificial intelligence.","amountUsd":null,"relevanceNote":null,"fundName":"Dimension I"},{"companyName":"Chroma Medicine","companyUrl":null,"stage":"Series B","sector":"Biotech / Gene Editing","investmentYear":null,"description":"A genomic medicine company pioneering single-dose epigenetic editing therapeutics to regulate gene expression without altering the underlying DNA sequence.","amountUsd":null,"relevanceNote":null,"fundName":"Dimension I"}],"partnerCount":1,"partners":[{"id":42259,"name":"Nan Li","title":"Co-founder & Managing Partner","seniority":null,"focusTags":["Biotech platforms","Lab tools","AI in biology"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":13023,"name":"Volition Capital Fund","slug":"volition-capital-fund","logoUrl":null,"website":"https://www.volitioncapital.com/","stageFocus":["Pre-Seed"],"sectorTags":["SaaS","AI / ML","Developer Tools","Other","Security"],"hqGeo":"Boston, MA"},{"id":13350,"name":"AI-Finspace Ventures","slug":"ai-finspace-ventures","logoUrl":null,"website":null,"stageFocus":["Seed"],"sectorTags":["Fintech","AI / ML","Healthcare","SaaS"],"hqGeo":"New York, NY"},{"id":7722,"name":"Sheesha Finance","slug":"sheesha-finance","logoUrl":null,"website":"https://sheeshafinance.gitbook.io/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Fintech"],"hqGeo":null},{"id":13762,"name":"NeuroNet Ventures","slug":"neuronet-ventures","logoUrl":null,"website":"https://neuronetgpo.com/","stageFocus":["Seed"],"sectorTags":["AI / ML","Other"],"hqGeo":"Chicago, IL"},{"id":497,"name":"SBI Investment (SBI Group)","slug":"sbi-investment-sbi-group","logoUrl":null,"website":"https://www.sbinvestment.co.jp/","stageFocus":["Seed","Series A"],"sectorTags":["Fintech","Other","Developer Tools"],"hqGeo":"Tokyo, Japan"},{"id":10061,"name":"dWeb Ventures","slug":"dweb-ventures","logoUrl":null,"website":"https://webventures.io/","stageFocus":["Seed"],"sectorTags":["Other","Developer Tools"],"hqGeo":"San Francisco, CA"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"ai","displayName":"AI & ML Investors","pageType":"industry"},{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"},{"slug":"series-b","displayName":"Series B Investors","pageType":"stage"}],"fundraisingResources":[{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":null}